Sirtuin 3 Deficiency Is Associated with Inhibited Mitochondrial Function and Pulmonary Arterial Hypertension in Rodents and Humans

Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes

Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193

Heart-Lung Transplantation

Yarbrough, W. M., Robbins, R. C., & Mallidi, H. R. (2016) · CRC Press eBooks · doi:10.3109/9781439802571-25 · Cited by 2,161

Regulation of cellular metabolism by protein lysine acetylation

Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

Bonnet, S., Archer, S. L., Allalunis‐Turner, J., Haromy, A., Beaulieu, C., Thompson, R. B., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S. B., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,552

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364

A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis

Ahn, B.-H., Kim, H.-S., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C.-X., & Finkel, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803790105 · Cited by 1,291

Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation

Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-07 · Cited by 1,216

Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases

Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,120

Mitochondrial Membrane Potential in Living Cells

Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,039

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome

Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787

SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress

Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.023 · Cited by 785

SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization

Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782

Partners in transcription: NFAT and AP-1

Macián, F., López‐Rodríguez, C., & Rao, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204386 · Cited by 766

Metabolic Modulation of Glioblastoma with Dichloroacetate

Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E. B., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D. S., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 744

An Abnormal Mitochondrial–Hypoxia Inducible Factor-1α–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats

Bonnet, S., Michelakis, E. D., Porter, C. J., Andrade-Navarro, M. A., Thébaud, B., Bonnet, S. B., Haromy, A., Harry, G., Moudgil, R., McMurtry, M. S., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.609008 · Cited by 604

Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5

Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C. F. W., & Steegborn, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.048 · Cited by 531

Disruption of the Ang II type 1 receptor promotes longevity in mice

Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36703 · Cited by 486

Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension

Marsboom, G., Tóth, P. T., Ryan, J. J., Hong, Z., Wu, X., Fang, Y.-H., Thenappan, T., Piao, L. H., Zhang, H. J., Pogoriler, J. E., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.263848 · Cited by 476

SIRT3 Deacetylates and Activates OPA1 To Regulate Mitochondrial Dynamics during Stress

Samant, S. A., Zhang, H. J., Hong, Z., Pillai, V. B., Sundaresan, N. R., Wolfgeher, D., Archer, S. L., Chan, D. C., & Gupta, M. P. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01483-13 · Cited by 446

Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM

Simoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441

Activation of Glycogen Synthase Kinase 3β Disrupts the Binding of Hexokinase II to Mitochondria by Phosphorylating Voltage-Dependent Anion Channel and Potentiates Chemotherapy-Induced Cytotoxicity

Pastorino, J. G., Hoek, J. B., & Shulga, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1925 · Cited by 405

Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.

Archer, S. L., Souil, E., Dinh‐Xuan, A. T., Schremmer, B., Mercier, J., Yaagoubi, A. E., Nguyen-Huu, L., Reeve, H. L., & Hampl, V. (1998) · Journal of Clinical Investigation · doi:10.1172/jci333 · Cited by 403

Alterations of cellular bioenergetics in pulmonary artery endothelial cells

Xu, W., Koeck, T., Lara, A., Neumann, D. R., DiFilippo, F. P., Koo, M., Janocha, A. J., Masri, F. A., Arroliga, A. C., Jennings, C. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605080104 · Cited by 401

Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer

Archer, S. L., Gomberg‐Maitland, M., Maitland, M. L., Rich, S., Garcia, J. G. N., & Weir, Ε. K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01324.2007 · Cited by 372

Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation

Hansmann, G., Wagner, R. A., Schellong, S., Pérez, V. D. J., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M. (2007) · Circulation · doi:10.1161/circulationaha.106.663120 · Cited by 367

Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity

Finley, L. W. S., Haas, W., Desquiret‐Dumas, V., Wallace, D. C., Procaccio, V., Gygi, S. P., & Haigis, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023295 · Cited by 364

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

Bonnet, S., Rochefort, G. Y., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 363

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 362

Cell-Permeating α -Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient Cells

MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359

Diversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing

Michelakis, E. D., Hampl, V., Nsair, A., Wu, X., Harry, G., Haromy, A., Gurtu, R., & Archer, S. L. (2002) · Circulation Research · doi:10.1161/01.res.0000024689.07590.c2 · Cited by 309

Attenuated K+ channel gene transcription in primary pulmonary hypertension

Yuan, X. J., Wang, J., Juhaszova, M., Gaine, S., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 297

Complex I Binding by a Virally Encoded RNA Regulates Mitochondria-Induced Cell Death

Reeves, M., Davies, A., Mcsharry, B. P., Wilkinson, G., & Sinclair, J. (2007) · Science · doi:10.1126/science.1142984 · Cited by 297

Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation

Jing, E., O’Neill, B. T., Rardin, M. J., Kleinridders, A., Ilkeyeva, O. R., Ussar, S., Bain, J. R., Lee, K. Y., Verdin, E. M., Newgard, C. B., et al. (2013) · Diabetes · doi:10.2337/db12-1650 · Cited by 283

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology

Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 275

The Metabolic Basis of Pulmonary Arterial Hypertension

Sutendra, G., & Michelakis, E. D. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.004 · Cited by 271

Insulin resistance in pulmonary arterial hypertension

Zamanian, R. T., Hansmann, G., Snook, S., Lilienfeld, D. E., Rappaport, K., Reaven, G. M., Rabinovitch, M., & Doyle, R. L. (2008) · European Respiratory Journal · doi:10.1183/09031936.00000508 · Cited by 269

Mitochondrial sirtuins: regulators of protein acylation and metabolism

He, W., Newman, J. C., Wang, M. Z., Ho, L., & Verdin, E. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.07.004 · Cited by 262

Peroxisome Proliferator-activated Receptor-γ Coactivator-1α Controls Transcription of the Sirt3 Gene, an Essential Component of the Thermogenic Brown Adipocyte Phenotype

Giralt, A., Hondares, E., Villena, J. A., Ribas, F., Díaz-Delfín, J., Giralt, M., Iglesias, R., & Villarroya, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202390 · Cited by 210

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Morrell, N. W., Atochina‐Vasserman, E. N., Morris, K. G., Danilov, S. M., & Stenmark, K. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118228 · Cited by 208

PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension

Ryan, J. J., Marsboom, G., Fang, Y.-H., Tóth, P. T., Morrow, E., Luo, N., Piao, L. H., Hong, Z., Ericson, K. J., Zhang, H. J., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1687oc · Cited by 194

Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer

Sutendra, G., Dromparis, P., Kinnaird, A. S., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2012) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 189

Signal Transducers and Activators of Transcription-3/Pim1 Axis Plays a Critical Role in the Pathogenesis of Human Pulmonary Arterial Hypertension

Paulin, R., Courboulin, A., Meloche, J., Mainguy, V., de la Roque, E. D., Saksouk, N., Côté, J., Provencher, S., Sussman, M. A., & Bonnet, S. (2011) · Circulation · doi:10.1161/circulationaha.110.963314 · Cited by 169

Unrecognized glucose intolerance is common in pulmonary arterial hypertension

Pugh, M. E., Robbins, I. M., Rice, T. W., West, J. D., Newman, J. H., & Hemnes, A. R. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.02.016 · Cited by 154

SIRT3 is Pro-Apoptotic and Participates in Distinct Basal Apoptotic Pathways

Allison, S. J., & Milner, J. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4866 · Cited by 147

Uncoupling Protein 2 Deficiency Mimics the Effects of Hypoxia and Endoplasmic Reticulum Stress on Mitochondria and Triggers Pseudohypoxic Pulmonary Vascular Remodeling and Pulmonary Hypertension

Dromparis, P., Paulin, R., Sutendra, G., Qi, A. C., Bonnet, S., & Michelakis, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300699 · Cited by 143

Heterogeneity in Lung 18 FDG Uptake in Pulmonary Arterial Hypertension

Zhao, L., Ashek, A., Wang, L., Fang, W., Dabral, S., Dubois, O., Cupitt, J., Pullamsetti, S. S., Cotroneo, E., Jones, H. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004136 · Cited by 140

Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice

Hartner, A. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg299 · Cited by 138

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

Courboulin, A., Tremblay, V. L., Barrier, M., Meloche, J., Jacob, M., Chapolard, M., Bisserier, M., Paulin, R., Lambert, C., Provencher, S., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-128 · Cited by 124

A potential role for insulin resistance in experimental pulmonary hypertension

West, J. D., Niswender, K. D., Johnson, J. A., Pugh, M. E., Gleaves, L. A., Fessel, J. P., & Hemnes, A. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00030312 · Cited by 123

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Germain, M., Eyries, M., Montani, D., Poirier, O., Girerd, B., Dorfmüller, P., Coulet, F., Nadaud, S., Maugenre, S., Guignabert, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2581 · Cited by 103

Characterization of a bidirectional promoter shared between two human genes related to aging: SIRT3 and PSMD13

Bellizzi, D., Dato, S., Cavalcante, P., Covello, G., Cianni, F. D., Passarino, G., Rose, G., & BENEDICTIS, G. D. (2006) · Genomics · doi:10.1016/j.ygeno.2006.09.004 · Cited by 89

Metabolic Adaptations of Three Inbred Strains of Mice (C57BL/6, DBA/2, and 129T2) in Response to a High-Fat Diet

Funkat, A., Massa, C. M., Jovanovska, V., Proietto, J., & Andrikopoulos, S. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3264 · Cited by 88

Blood Pressure, Cardiac, and Renal Responses to Salt and Deoxycorticosterone Acetate in Mice

Wang, Q., Hümmler, E., Nussberger, J., Clément, S., Gabbiani, G., Brunner, H. R., & Burnier, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000017902.77985.84 · Cited by 78

Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-κB activation and oxidative stress

Derdák, Z., Fülöp, P., Sabo, E., Tavares, R., Berthiaume, E. P., Resnick, M. B., Paragh, G., Wands, J. R., & Baffy, G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi335 · Cited by 77

Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.

Kluge, R., Barthel, H., Pankau, H., Seese, A., Schauer, J., Wirtz, H., Seyfarth, H.-J., Steinbach, J., Sabri, O., & Winkler, J. (2005) · PubMed · Cited by 53

Differential Regulation of Hypoxia-Inducible Factor-1 through Receptor Tyrosine Kinase Transactivation in Vascular Smooth Muscle Cells

Lauzier, M.-C., Pagé, E. L., Michaud, M. D., & Richard, D. E. (2007) · Endocrinology · doi:10.1210/en.2007-0285 · Cited by 47

Uncoupling Protein 2 Promoter Polymorphism −866G/A, Central Adiposity, and Metabolic Syndrome in Asians

Shen, H., Qi, L., Tai, E. S., Chew, S. K., Tan, C. E., & Ordovás, J. M. (2006) · Obesity · doi:10.1038/oby.2006.74 · Cited by 47

Unrecognized Glucose Intolerance Is Common In Pulmonary Arterial Hypertension

Pugh, M. E., Hemnes, A. R., Robbins, I. M., Rice, T. W., & Newman, J. H. (2010) · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4813 · Cited by 34

Sirtuin 3 Deficiency Does Not Augment Hypoxia-Induced Pulmonary Hypertension

Waypa, G. B., Osborne, S. W., Marks, J. D., Berkelhamer, S. K., Kondapalli, J., & Schumacker, P. T. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0191oc · Cited by 32

PGC-1αInduction in Pulmonary Arterial Hypertension

Mata, M., Sarrión, I., Milián, L., Juan, G., Ramón, M., Naufal, D., Gil, J. L. S., Ridocci, F., Fabregat‐Andrés, Ó., & Cortijo, J. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/236572 · Cited by 30

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Humbert, M. J. C., Guignabert, C., Bonnet, S., Dorfmüller, P., Klinger, J. R., Nicolls, M. R., Olschewski, A., Pullamsetti, S. S., SCHERMULY, R. T., Stenmark, K. R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01887-2018 · Cited by 1,282

Mitochondria in health, disease, and aging

Harrington, J. S., Ryter, S. W., Plataki, M. E., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 641

Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases

Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 497

Protective effects of sirtuins in cardiovascular diseases: from bench to bedside

Winnik, S., Auwerx, J., Sinclair, D. A., & Matter, C. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv290 · Cited by 422

Metabolic control of epigenetics in cancer

Kinnaird, A. S., Zhao, S., Wellen, K. E., & Michelakis, E. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.82 · Cited by 429

Abstract 18830: Mitochondrial Suppression Due to Loss of Sirt3 Deacetylase Activity Causes Pulmonary Arterial Hypertension

Paulin, R., Dromparis, P., Sutendra, G., Provencher, S., Bonnet, S., & Michelakis, E. D. (2013) · Circulation · doi:10.1161/circ.128.suppl_22.a18830

Abstract 17011: Loss-of-function SIRT3 Single Nucleotide Polymorphisms in Patients With Pulmonary Arterial Hypertension (PAH): Insights into the Metabolic Basis of PAH

Gurtu, V., Paulin, R., Webster, L., PATERSON, I. S., Provencher, S., Bonnet, S., & Michelakis, E. D. (2013) · Circulation

Abstract 19386: The Mitochondrial Deacetylase Sirtuin 3 (sirt3) is Important in the Pathogenesis of Both Pulmonary Hypertension and Pulmonary Fibrosis: Potential for an “Overlap Syndrome” and a Common Therapy?

Paulin, R., Zang, H., Boukouris, A. E., Gurtu, V., Haromy, A., & Michelakis, E. D. (2015) · Circulation · doi:10.1161/circ.132.suppl_3.19386

Abstract 13575: Lack of Both Mitochondrial Proteins Sirt3 and Ucp2 in Mice Recapitulates Many Critical Features of Human Pulmonary Arterial Hypertension (PAH), Including Inflammatory Plexogenic Lesions, Supporting the Metabolic Theory of PAH

Zhang, Y., Zervopoulos, S. D., Boukouris, A. E., Saleme, B., Liu, Y., Haromy, A., Webster, L., Dakhili, S. A. T., Ussher, J. R., Sutendra, G., et al. (2020) · Circulation · doi:10.1161/circ.142.suppl_3.13575

SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension

Li, M., Plecitá‐Hlavatá, L., Dobrinskikh, E., McKeon, B. A., Gandjeva, A., Riddle, S. R., Laux, A., Prasad, R. R., Kumar, S., Tuder, R. M., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0360oc · Cited by 35